Search results

Meeting of minds about potential next-generation cancer treatment for Australians

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

See details of previously published customer updates from our Health products team. 

Australia’s new state-of-the-art nuclear medicine facility gets green light.

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

Early research at ANSTO has contributed to development of innovative submicron particle encapsulation technology.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Melbourne researchers map the structure of a key COVID-19 protein using the Australian Synchrotron

Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.

ANSTO completed an international overnight dash for nuclear medicine earlier this week, chartering three planes to get potentially life-saving children’s cancer treatments from Japan to hospitals across Australia.

Commitment to undertake health research.